Van Diest Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$523K Sell
436
-624
-59% -$638K 0.47% 62
2026
Q1
$974K Buy
1,060
+495
+88% +$502K 0.77% 31
2025
Q4
$607K Buy
+565
New +$540K 0.91% 24

Other funds holding LLY

Van Diest Capital's LLY Position: Q2 2026 in Review

Van Diest Capital reduced its Eli Lilly (LLY) stake by 59% in Q2 2026, selling an estimated $638K and leaving 436 shares worth $523K. The position accounts for 0.47% of the portfolio, ranked #62.

Van Diest Capital first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $974K in Q1 2026. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Van Diest Capital held 436 shares of Eli Lilly worth $523K as of Q2 2026.
  • Van Diest Capital sold 624 Eli Lilly shares in Q2 2026, an estimated $638K.
  • Eli Lilly made up 0.47% of Van Diest Capital's portfolio in Q2 2026, its #62 holding.
  • Van Diest Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Van Diest Capital's Eli Lilly position peaked at $974K in Q1 2026.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Van Diest Capital's 13F filing for Q2 2026, filed 4 Aug 2026.